Keyphrases
Asthma
100%
Alarmins
100%
Airway Epithelium
100%
Anti-interleukin-1
75%
Eosinophils
50%
Interleukin-5 (IL-5)
50%
Interleukin-13 (IL-13)
50%
Fractional Exhaled Nitric Oxide (FeNO)
50%
Anti-interleukin 5
50%
Interleukin-4R
50%
Inflammatory Pathways
25%
Inflammatory Response
25%
Interleukin-33 (IL-33)
25%
Treatment Outcome
25%
Severe Disease
25%
Biological Treatment
25%
Effective Treatment
25%
Disease Burden
25%
Lung Function
25%
Clinical Phenotype
25%
Interleukin-4 (IL-4)
25%
Putative Drug Targets
25%
Eosinophilic Inflammation
25%
Immunoglobulin E
25%
Inflammatory Cascade
25%
Exacerbation Rate
25%
Significant Disease
25%
Strong Potential
25%
Severe Asthma
25%
Mucus Production
25%
Therapeutic Monoclonal Antibody
25%
Bronchospasm
25%
Immunological Pathways
25%
Thymic Stromal Lymphopoietin
25%
Type 2 Airway Inflammation
25%
Epithelial Cytokines
25%
Interleukin-25
25%
Pharmacology, Toxicology and Pharmaceutical Science
Cytokine
100%
Asthma
100%
Biological Product
100%
Alarmin
100%
Interleukin 5
80%
Inflammation
40%
Nitric Oxide
40%
Interleukin 13
40%
Population Study
20%
Disease
20%
Biological Marker
20%
Respiratory Tract Inflammation
20%
Monoclonal Antibody
20%
Interleukin 4
20%
Immunoglobulin E
20%
Bronchospasm
20%
Thymic Stromal Lymphopoietin
20%
Interleukin 33
20%
Immunoglobulin Antibody
20%
Interleukin 25
20%
Immunology and Microbiology
Cytokine
100%
Asthma
100%
Biological Product
100%
Interleukin 5
80%
Interleukin
60%
Interleukin 13
40%
Exhaled Nitric Oxide
40%
Eosinophil Granulocyte
40%
Population Research
20%
Inflammation Response
20%
Interleukin 33
20%
Interleukin 4
20%
Immunoglobulin E
20%
Disease Burden
20%
Bronchospasm
20%
Severe Asthma
20%
Immunoglobulin Antibody
20%
Thymic Stromal Lymphopoietin
20%
Monoclonal Antibody Therapy
20%
Interleukin 25
20%